
09/06/2025
Tom Watanabe, MD, Clinical Director of the Moss Traumatic Brain Injury Model System, and colleague Jaime Ott, DO, recently published a narrative review on the clinical use of alpha-2 receptor agonist medications in the treatment of sequelae. The review highlights key considerations for clinicians, including potential indications and side effects, to support informed decision-making in patient care.
👉 Read the full article here: https://pubmed.ncbi.nlm.nih.gov/40845906/